US Dollar vs MXN

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

BDTX Black Diamond Therapeutics Inc

4.78

0.02 (0.42%)

31 May 2024 - Cerrado

Retrasado por 15 minutos

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Black Diamond Therapeutics (NASDAQ:BDTX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Haga Click aquí para más Gráficas Black Diamond Therapeutics.

Black Diamond Therapeutics (NASDAQ:BDTX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024

Haga Click aquí para más Gráficas Black Diamond Therapeutics.

Noticias sobre Black Diamond Therapeutics Inc BDTX

Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Sábado 1 de Junio 2024 (24 horas hace) • GlobeNewswire Inc.

Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
Miércoles 29 de Mayo 2024 (4 días hace) • GlobeNewswire Inc.

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Lunes 13 de Mayo 2024 (3 semanas hace) • Edgar (US Regulatory)

Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Jueves 9 de Mayo 2024 (3 semanas hace) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jueves 9 de Mayo 2024 (3 semanas hace) • Edgar (US Regulatory)

Form 8-K - Current report
Jueves 9 de Mayo 2024 (3 semanas hace) • Edgar (US Regulatory)

Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Miércoles 24 de Abril 2024 (1 mes hace) • GlobeNewswire Inc.

Black Diamond Therapeutics Announces Changes to Board of Directors
Jueves 11 de Abril 2024 (2 meses hace) • GlobeNewswire Inc.

Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting
Domingo 7 de Abril 2024 (2 meses hace) • GlobeNewswire Inc.

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
Miércoles 3 de Abril 2024 (2 meses hace) • GlobeNewswire Inc.

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Martes 12 de Marzo 2024 (3 meses hace) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Lunes 11 de Marzo 2024 (3 meses hace) • Edgar (US Regulatory)

Más de Black Diamond Therapeutics Inc Artículos de Noticias

SG Issuer Sg Issuer Zc J...

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones